Loading...

Fresh2 Group Limited

FRESNASDAQ
Healthcare
Biotechnology
$0.85
$-0.26(-23.42%)

Fresh2 Group Limited (FRES) Company Profile & Overview

Explore Fresh2 Group Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Fresh2 Group Limited (FRES) Company Profile & Overview

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

SectorHealthcare
IndustryBiotechnology
CEOHaohan Xu

Contact Information

650 5th Ave, New York City, NY, 10019-6108

Company Facts

75 Employees
IPO DateJan 30, 2020
CountryUS

Frequently Asked Questions

;